About Us Microbiome What We Do Careers

KNOWLEDGE HUB

Serving microbiome innovators as the best-in-class CDMO means keeping our fingertips on the pulse of the industry. Discover what's new and what's next in this fast-moving field.

RESOURCES FROM ARRANTA

LATEST MICROBIOME INDUSTRY NEWS

MARCH 2021

Transverse aortic constriction induces gut barrier alterations, microbiota remodeling and systemic inflammation - Nature

Exclusive: Pendulum Therapeutics Swings $54M Series C To Bridge Gap Between Supplements, Prescription Drugs - crunchbase

$3M Grant Awarded to Orthopedics Researcher to Study the Role of the Gut Microbiome on Osteoarthritis - University of Colorado Anschutz Medical Campus

Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome-Based Therapy for Improving Cancer Immunotherapy - MyBiotics Ltd.

Tumour neoantigen mimicry by microbial species in cancer immunotherapy - Nature

Single strain control of microbial consortia - Nature

Evaluation of the gut microbiome in association with biological signatures of inflammation in murine polytrauma and shock - Scientific Reports

The microbiome and human cancer - Science

Arranta Bio Announces Addition of 130,000 sq. ft. Boxborough, Mass., Manufacturing Facility to Supply Clinical and Commercial Microbiome Products for Clients and closes Series B Equity Financing

4D pharma Announces Completion of Merger With Longevity Acquisition Corporation - Business Wire

MaaT links microbiome drug to GvHD responses, plans phase 3 - FierceBiotech
Startup pursues new drugs for human diseases by searching gut microbes from wild animals - FierceBiotech
Modulating gut microbiota to treat cancer - Science
Ecology-guided prediction of cross-feeding interactions in the human gut microbiome - Nature
Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation - Nature
Dissecting the contribution of host genetics and the microbiome in complex behaviors - Cell
Associations between the gut microbiome and fatigue in cancer patients - Scientific Reports
The microbiome and human cancer - Science
Single strain control of microbial consortia - Nature Communications
Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME) - Scientific Reports
Standardization of microbiome studies for urolithiasis: an international consensus agreement - Nature Reviews Urology
FEBRUARY 2021
How gut microbes could drive brain disorders - Nature
Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation - Nature
Editing the microbiome - PNAS
Evolve BioSystems Announces Major Strategic Investment from Cargill and Manna Tree to Support Innovative Probiotic that Dramatically Improves Infant Gut Health
Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health

Learn more about Arranta Bio and our commitment to microbiome innovators and the patients they serve by downloading our latest articles with interviews from our SMEs.

Read the latest press releases and news from Arranta Bio.

white paper request

Coming Soon: Reserve a copy of our upcoming white paper.

placeholder

Videos, presentations, and interviews with our subject matter experts.

C O N T A C T

Get in Touch

We're always open to engaging with individuals interested in our company or the microbiome therapy market in general.

We look forward to hearing from you.

Headquarters &
cGMP Manufacturing
650 Pleasant Street
Watertown, MA 02472

Process Development
& cGMP Manufacturing
1622 NW 55th Pl.
Gainesville, FL 32653

info@arrantabio.com

For CDMO Service Inquiries: bd@arrantabio.com